Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
The approximate half-life of retatrutide is approximately 6 days making it suitable for once weekly administration [2]
The study provides important insights for clinical practice and future research
Mean body weight (95.8 kg at baseline) was reduced by 5.6 kg with semaglutide and 1.9 kg with exenatide ER (ETD -3.78 kg [95% CI -4.58, -2.98]
In China, a continuous R&D pipeline in novel drug discovery, coupled with injectable and oral formulations, is employed in non-alcoholic steatohepatitis (NASH) and Alzheimer's disease, escalating market growth
Supplied as sterile lyophilized powder for laboratory and in vitro research applications
US$ 27.40
US$ 29.13
US$ 26.61
US$ 29.54
US$ 29.04
US$ 21.96
US$ 21.18
